Lupin saw the highest growth of 2.32% in patent filings in April and 2.49% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 2.32% and grants by 0.66%. GlobalData’s DataBook provides a comprehensive analysis of Lupin‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Lupin has been focused on protecting inventions in United States(US) with six publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 50% filings and 14% grants. The United States(US), European Patent Office(EPO), Chile(CL), and Denmark(DK) patent Office are among the top ten patent offices where Lupin is filings its patents. Among the top granted patent authorities, Lupin has 14% of its grants in United States(US) and 14% in Australia(AU).
Roche and Johnson & Johnson could be the strongest competitors for Lupin
Patents related to rare diseases lead Lupin's portfolio
Lupin has the highest number of patents in rare diseases. For rare diseases no patents were filed and 100% of patents were granted in Q2 2024.
Inhalers related patents lead Lupin portfolio followed by breast cancer, and melanoma
Lupin has highest number of patents in inhalers followed by breast cancer, melanoma, sarcomas, and small-cell lung cancer.
For comprehensive analysis of Lupin's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
